Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 3,593 | 0 | N/A | N/A |
| Receivables | 15,130 | 0 | N/A | N/A |
| Inventories | 17,625 | 0 | N/A | N/A |
| TOTAL | $41,551 | $0 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 3,202 | 0 | N/A | N/A |
| Intangibles | 25,118 | 0 | 0 | 0 |
| Other Non-Current Assets | 50,100 | 0 | 0 | 0 |
| TOTAL | $78,420 | $N/A | $N/A | $N/A |
| Total Assets | $119,971 | $0 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 11,472 | 0 | 0 | 0 |
| Accrued Expenses | 4,118 | 0 | N/A | N/A |
| Other current liabilities | 3,365 | 0 | N/A | N/A |
| TOTAL | $19,835 | $0 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Deferred Revenues | 880 | N/A | N/A | N/A |
| TOTAL | $5,528 | $N/A | $N/A | $N/A |
| Total Liabilities | $25,363 | $0 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Retained earnings | -172,671 | 0 | N/A | N/A |
| Other shareholders' equity | 267,279 | 0 | 0 | 0 |
| TOTAL | $94,608 | $0 | $N/A | $N/A |
| Total Liabilities And Equity | $119,971 | $0 | $0 | $0 |